Statin Labels to Add Possible Side Effects

U.S. labels for statin drugs now will list warnings about two new possible side effects. Some people taking statins have had a temporary loss of short-term memory. Some people have shown a higher risk of developing type 2 diabetes. The new labels will mention these potential risks. The U.S. Food and Drug Administration (FDA) issued the changes February 28. Statins include drugs such as atorvastatin (Lipitor), simvastatin (Zocor) and rosuvastatin (Crestor). They are used to lower LDL cholesterol and to help prevent heart attacks. The FDA says the memory problems have not been serious and went away when people stopped taking statins. Recent research has found that the increased risk of diabetes is small but real for people taking higher doses of statins. The new labels also will drop previous advice to have people taking statins get regular blood tests for liver enzymes.

Content restricted. Requires subscription